Towards broadly protective hantavirus vaccine: Immunological barriers, structural vaccinology and one health perspectives
Authors:
- Seyi Samson EnitanSESeyi Samson Enitan
- Chinedu-Madu Jane UgochiCUChinedu-Madu Jane Ugochi
- Chukwudi Amaechi OfodileCOChukwudi Amaechi Ofodile
- Comfort Bosede EnitanCEComfort Bosede Enitan
- Richard Yomi AkeleRARichard Yomi Akele
- Ayodeji Olusola OlayanjuAOAyodeji Olusola Olayanju
- Grace Eleojo ItodoGIGrace Eleojo Itodo
- Chukwuma J. OkaforCOChukwuma J. Okafor
- Tolulope Joseph OgunniyiTOTolulope Joseph Ogunniyi
Open Access
- 20 August 2026
- journal article
- Published by Elsevier in Clinical Immunology Communications
- Vol. 10
Abstract
No abstract availableThis publication has 69 references indexed in Scilit:
- Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infectionCell, 2021
- Adenoviral vector‐based platforms for developing effective vaccines to combat respiratory viral infectionsClinical & Translational Immunology, 2021
- Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2Cell, 2020
- Hantavirus entry: Perspectives and recent advances2019
- Hantavirus infection: a global zoonotic challengeVirologica Sinica, 2017
- Environmental factors affecting transmission risk for hantaviruses in forested portions of southern BrazilActa Tropica, 2011
- Recent Advances in Hantavirus Molecular Biology and Disease2011
- Human immune response to Puumala virus glycoproteins and nucleocapsid protein expressed in mammalian cellsJournal of Medical Virology, 2001
- DNA Vaccination with Hantavirus M Segment Elicits Neutralizing Antibodies and Protects against Seoul Virus InfectionVirology, 1999
- Hantavirus Pulmonary Syndrome: CD8+and CD4+Cytotoxic T Lymphocytes to Epitopes on Sin Nombre Virus Nucleocapsid Protein Isolated during Acute IllnessVirology, 1997